CELC ▲ +1.1% - Celcuity Inc. $CELC int Overweight @ JPM pt 157 JPMorgan initiated coverage of Celcuity with an Overweight rating and a $157 price target, providing institutional validation for the diagnostics company and lifting shares 1.1% on the positive analyst stance. 17-SEP-2026 06:27 AM ET